Cancer Genetics and NovellusDx Sign Definitive Agreement to Merge
September 18, 2018 08:30 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J. and JERUSALEM, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through...
Cancer Genetics Reports Second Quarter 2018 Financial Results and Provides Strategic Business Updates
August 14, 2018 07:30 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers...
Cancer Genetics to Report Second Quarter 2018 Financial Results on August 14, 2018
August 07, 2018 16:05 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
Cancer Genetics Closes $2.625 million Convertible Note Financing
July 18, 2018 16:05 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., July 18, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
Cancer Genetics Strengthens Management Team with Appointment of Michael McCartney as Chief Commercial Officer
June 12, 2018 08:00 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., June 12, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
Cancer Genetics Reports First Quarter 2018 Financial Results and Provides Strategic Business Updates
May 15, 2018 07:00 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., May 15, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
Cancer Genetics to Report First Quarter 2018 Financial Results on May 15, 2018
May 10, 2018 16:05 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., May 10, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
Cancer Genetics Announces Sale of India Operations to REPROCELL Incorporated
April 27, 2018 08:30 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., April 27, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
Cancer Genetics’ Unique Tissue of Origin Test (TOO®) Receives Special FDA 510(k) Clearance
April 16, 2018 07:30 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., April 16, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
Cancer Genetics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Strategic Business Updates
April 02, 2018 16:01 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., April 02, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...